498 related articles for article (PubMed ID: 15019079)
1. Transport characteristics of 9-nitrocamptothecin in the human intestinal cell line Caco-2 and everted gut sacs.
Sha X; Fang X
Int J Pharm; 2004 Mar; 272(1-2):161-71. PubMed ID: 15019079
[TBL] [Abstract][Full Text] [Related]
2. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2.
Yu L; Zeng S
J Pharm Pharmacol; 2007 May; 59(5):655-60. PubMed ID: 17524230
[TBL] [Abstract][Full Text] [Related]
3. [The in vitro kinetics of uptake, transport and efflux of 9-nitrocamptothecin in Caco-2 cell model].
Sha XY; Fang XL; Wu YJ
Yao Xue Xue Bao; 2004 Oct; 39(10):839-43. PubMed ID: 15700828
[TBL] [Abstract][Full Text] [Related]
4. The intestinal absorption of camptothecin, a highly lipophilic drug, across Caco-2 cells is mediated by active transporter(s).
Gupta E; Luo F; Lallo A; Ramanathan S; Vyas V; Rubin E; Sinko P
Anticancer Res; 2000; 20(2A):1013-6. PubMed ID: 10810389
[TBL] [Abstract][Full Text] [Related]
5. Transport characteristics of candesartan in human intestinal Caco-2 cell line.
Zhou L; Chen X; Gu Y; Liang J
Biopharm Drug Dispos; 2009 Jul; 30(5):259-64. PubMed ID: 19562680
[TBL] [Abstract][Full Text] [Related]
6. Transport characteristics of rutin deca (H-) sulfonate sodium across Caco-2 cell monolayers.
He Y; Zeng S
J Pharm Pharmacol; 2005 Oct; 57(10):1297-303. PubMed ID: 16259758
[TBL] [Abstract][Full Text] [Related]
7. Segmental dependent transport of low permeability compounds along the small intestine due to P-glycoprotein: the role of efflux transport in the oral absorption of BCS class III drugs.
Dahan A; Amidon GL
Mol Pharm; 2009; 6(1):19-28. PubMed ID: 19248230
[TBL] [Abstract][Full Text] [Related]
8. Intestinal transport of irinotecan in Caco-2 cells and MDCK II cells overexpressing efflux transporters Pgp, cMOAT, and MRP1.
Luo FR; Paranjpe PV; Guo A; Rubin E; Sinko P
Drug Metab Dispos; 2002 Jul; 30(7):763-70. PubMed ID: 12065434
[TBL] [Abstract][Full Text] [Related]
9. Transport of rhodamine 123, a P-glycoprotein substrate, across rat intestine and Caco-2 cell monolayers in the presence of cytochrome P-450 3A-related compounds.
Yumoto R; Murakami T; Nakamoto Y; Hasegawa R; Nagai J; Takano M
J Pharmacol Exp Ther; 1999 Apr; 289(1):149-55. PubMed ID: 10086998
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms underlying saturable intestinal absorption of metformin.
Proctor WR; Bourdet DL; Thakker DR
Drug Metab Dispos; 2008 Aug; 36(8):1650-8. PubMed ID: 18458049
[TBL] [Abstract][Full Text] [Related]
11. Assessment of intestinal absorption of vitexin-2''-o-rhamnoside in hawthorn leaves flavonoids in rat using in situ and in vitro absorption models.
Xu YA; Fan G; Gao S; Hong Z
Drug Dev Ind Pharm; 2008 Feb; 34(2):164-70. PubMed ID: 18302035
[TBL] [Abstract][Full Text] [Related]
12. Nonlinear absorption of methylprednisolone by absorptive and secretory transporters.
Tomita M; Watanabe A; Fujinaga I; Yamakawa T; Hayashi M
Int J Pharm; 2010 Mar; 387(1-2):1-6. PubMed ID: 19883743
[TBL] [Abstract][Full Text] [Related]
13. Intestinal transport of bis(12)-hupyridone in Caco-2 cells and its improved permeability by the surfactant Brij-35.
Yu H; Hu YQ; Ip FC; Zuo Z; Han YF; Ip NY
Biopharm Drug Dispos; 2011 Apr; 32(3):140-50. PubMed ID: 21271607
[TBL] [Abstract][Full Text] [Related]
14. Co-treatment with grapefruit juice inhibits while chronic administration activates intestinal P-glycoprotein-mediated drug efflux.
Panchagnula R; Bansal T; Varma MV; Kaul CL
Pharmazie; 2005 Dec; 60(12):922-7. PubMed ID: 16398269
[TBL] [Abstract][Full Text] [Related]
15. Kinetic profiling of P-glycoprotein-mediated drug efflux in rat and human intestinal epithelia.
Stephens RH; O'Neill CA; Warhurst A; Carlson GL; Rowland M; Warhurst G
J Pharmacol Exp Ther; 2001 Feb; 296(2):584-91. PubMed ID: 11160647
[TBL] [Abstract][Full Text] [Related]
16. Multiple efflux pumps are involved in the transepithelial transport of colchicine: combined effect of p-glycoprotein and multidrug resistance-associated protein 2 leads to decreased intestinal absorption throughout the entire small intestine.
Dahan A; Sabit H; Amidon GL
Drug Metab Dispos; 2009 Oct; 37(10):2028-36. PubMed ID: 19589874
[TBL] [Abstract][Full Text] [Related]
17. pH-dependent functional activity of P-glycoprotein in limiting intestinal absorption of protic drugs: kinetic analysis of quinidine efflux in situ.
Varma MV; Panchagnula R
J Pharm Sci; 2005 Dec; 94(12):2632-43. PubMed ID: 16258992
[TBL] [Abstract][Full Text] [Related]
18. Sulfasalazine transport in in-vitro, ex-vivo and in-vivo absorption models: contribution of efflux carriers and their modulation by co-administration of synthetic nature-identical fruit extracts.
Mols R; Deferme S; Augustijns P
J Pharm Pharmacol; 2005 Dec; 57(12):1565-73. PubMed ID: 16354400
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the regional intestinal kinetics of drug efflux in rat and human intestine and in Caco-2 cells.
Makhey VD; Guo A; Norris DA; Hu P; Yan J; Sinko PJ
Pharm Res; 1998 Aug; 15(8):1160-7. PubMed ID: 9706044
[TBL] [Abstract][Full Text] [Related]
20. Polarized efflux of mono- and diacid metabolites of ME3229, an ester-type prodrug of a glycoprotein IIb/IIIa receptor antagonist, in rat small intestine.
Okudaira N; Komiya I; Sugiyama Y
J Pharmacol Exp Ther; 2000 Nov; 295(2):717-23. PubMed ID: 11046110
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]